AzTrials
AzTrials

ExercisePERFORM-RLNCT06653049

An Evaluation of the Effect of App-Based Exercise Prescription Using RL on Satisfaction and Exercise Intensity

A study testing Reinforcement Learning (RL) Personalised Exercise Prescription via i80 BPM App and Generic Non-Personalised Exercise Prescription via i80 BPM App in people with Exercise and Mobile Applications, run by University College Dublin at 1 site in Ireland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The PERFORM-RL study (Personalised Exercise Prescription for Remote Fitness Using Reinforcement Learning) was a 12-week randomised crossover trial designed to evaluate the effectiveness of an app-based exercise prescription system powered by reinforcement learning (RL). Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Exercise, Mobile Applications
What is being tested?
Reinforcement Learning (RL) Personalised Exercise Prescription via i80 BPM App and Generic Non-Personalised Exercise Prescription via i80 BPM App
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
69 participants
Where
1 siteIreland
Study dates
1 Sep 2022to 30 Nov 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy, recreationally active adults aged 18 to 65 years. Able to engage in aerobic activity for a total of 80 minutes at moderate intensity, no more than two times per week.
  • Able to provide informed consent. Ability to read and understand English to engage with the study materials and complete the app-based exercises.
  • Access to a compatible smartphone to download and use the i80 BPM app.

Who cannot join

  • Individuals with any physical disability or motor impairment that prevents participation in exercise.
  • Individuals with severe cognitive impairment. Individuals unable to read or write in English. Known contraindications to exercise, as identified by the 'Exercise Preparticipation Health Screening Questionnaire for Exercise Professionals'.
  • Participation in another clinical trial or study that could interfere with the trial results.
  • Engaging in high-level or professional athletic training or more than three days of vigorous physical activity per week.

Trial locations and contacts

1 site in 1 country.

Ireland1 site
  • University College Dublin

    Dublin, Co. Dublin, D04C7X2

Other trials in Ireland

About this study

Official title: An Evaluation of the Effect of App-Based Exercise Prescription Using RL on Satisfaction and Exercise Intensity: Randomized Crossover Trial.

The PERFORM-RL study (Personalised Exercise Prescription for Remote Fitness Using Reinforcement Learning) was a 12-week randomised crossover trial designed to evaluate the effectiveness of an app-based exercise prescription system powered by reinforcement learning (RL). The study aimed to investigate whether exercise sessions tailored by RL would lead to greater user satisfaction and higher exercise intensity compared to generic, non-personalised exercise sessions.

The trial enrolled 62 participants (27 males, 42 females; mean age 42 years) who were randomly assigned to alternate between two conditions: an RL-driven intervention, which personalised exercise sessions based on user preferences and feedback, and a control condition with non-tailored, generic exercise sessions. Participants were instructed to complete three exercise sessions per week using the i80 BPM app, which offered a variety of video-guided exercises. The RL model customised these sessions based on user feedback, including satisfaction and perceived intensity, with the goal of optimising future sessions.

Read more

The primary outcome was user satisfaction, measured via the Physical Activity Enjoyment Scale (PACES-8) after each session. Secondary outcomes included exercise intensity, as assessed by the Borg Rating of Perceived Exertion (RPE) scale, and heart rate data collected through a Samsung Galaxy Fit 2 smartwatch.

The trial was conducted in Dublin, Ireland, and approved by the UCD Human Research Ethics Committee (LS-21-34-Tragos-Lawlor). Participants provided informed consent and were blinded to their group allocation. The trial was not registered prospectively, but steps are being taken for retrospective registration.

Read the detailed description

Study Overview The PERFORM-RL study was a 12-week randomised crossover trial conducted to evaluate the impact of app-based personalised exercise prescription on user satisfaction and exercise intensity, using reinforcement learning (RL) as the key mechanism for customisation. This study sought to determine whether RL-generated exercise sessions could improve user satisfaction and increase exercise intensity compared to non-personalised, generic sessions. The findings are expected to contribute to the growing field of digital health interventions, particularly in the area of scalable, app-based exercise programmes designed to enhance user engagement and long-term adherence.

Study Objectives The primary objective of the study was to compare user satisfaction between RL-generated exercise sessions and generic sessions. The hypothesis was that RL-driven personalisation would result in higher user satisfaction, as measured by the Physical Activity Enjoyment Scale (PACES-8). The secondary objective was to evaluate the effect of RL on exercise intensity, as measured by the Borg Rating of Perceived Exertion (RPE) scale. It was hypothesised that participants would exercise at a higher intensity in the RL condition due to the tailored nature of the sessions, which aligned with their preferences and fitness levels.

Study Design

This was a randomised, assessor-blinded crossover trial. Each participant completed two different conditions during the 12-week study:

Intervention Condition: Exercise sessions were personalised using a reinforcement learning model that adapted session difficulty and content based on participant preferences, past performance, and feedback.

Control Condition: Participants completed generic, non-personalised exercise sessions. These sessions were pre-designed and did not adapt based on the user's feedback or preferences.

Participants alternated weekly between the intervention and control conditions, meaning that each week they experienced a different approach to exercise prescription. This design ensured that each participant acted as their own control, reducing variability and increasing the robustness of the findings. All exercise sessions were delivered through the i80 BPM app, developed by Samsung, which also facilitated data collection.

Participants Participants were recruited from Dublin, Ireland, and its surrounding areas via word of mouth and social media. A total of 62 participants (27 males, 42 females; mean age 42 years) completed at least one exercise session, with 559 sessions completed overall during the 12-week trial period. Participants were healthy, recreationally active adults aged 18 to 65 years. They were screened for eligibility using the "Exercise Preparticipation Health Screening Questionnaire for Exercise Professionals." Exclusion criteria included physical disability, severe cognitive impairment, or an inability to read and write in English.

Interventions Reinforcement Learning (RL) Intervention

The RL model employed by the i80 BPM app personalised exercise sessions based on user preferences, perceived exertion, and feedback from previous sessions. The RL framework used a decision-making agent, which selected exercises from a pre-existing database based on the user's fitness level, goals, and real-time feedback. The model's reward function aimed to maximise user satisfaction and session effectiveness by adapting the exercise difficulty and content in response to the user's evolving needs.

For example, if a participant reported high satisfaction and moderate intensity in a previous session, the RL model would suggest similar or slightly more challenging exercises for the next session. The RL system continuously learned from user interactions, adjusting the exercise prescription to maintain optimal engagement and effectiveness.

Control Condition

In the control condition, participants received generic exercise sessions that were not personalised or adapted based on user feedback. These sessions included a fixed selection of exercises and did not evolve over time, providing a baseline against which the personalised RL intervention could be compared.

Outcome Measures Primary Outcome: User Satisfaction

User satisfaction was assessed after each session using an abbreviated 8-item version of the Physical Activity Enjoyment Scale (PACES-8). This validated scale measures the extent to which participants enjoyed their exercise sessions. Scores range from 1 (low satisfaction) to 5 (high satisfaction), with higher scores indicating greater enjoyment and overall satisfaction with the exercise experience.

Secondary Outcome: Exercise Intensity

Exercise intensity was measured using the Borg Rating of Perceived Exertion (RPE) scale, which ranges from 1 (very easy) to 10 (maximum exertion). Participants were prompted to rate their perceived exertion after each session via the app, ensuring real-time capture of their experience. Heart rate data, collected using a Samsung Galaxy Fit 2 smartwatch, served as an additional measure of intensity, validating the subjective RPE scores.

Additional Outcome: Heart Rate

Heart rate was continuously monitored during each session using the Samsung Galaxy Fit 2 smartwatch. The heart rate data was automatically relayed to the i80 BPM app and used to track physiological responses to the exercise sessions.

Data Collection and Management Data were collected through the i80 BPM app, which recorded user satisfaction, exercise intensity, heart rate, and the duration of each exercise session. To ensure participant confidentiality, all data were anonymised before analysis. Participants were assigned a unique identification code, and all sensitive documents were stored securely, with only authorised personnel granted access.

Sample Size and Power Calculations Based on a previous feasibility study, the sample size was estimated to be a minimum of 40 participants to detect a mean difference of 8 points on the PACES-8 scale with 80% power. A total of 69 participants were recruited to account for potential dropouts, and 62 participants completed at least one exercise session. The final sample size provided sufficient power to detect differences between the RL and control conditions.

Statistical Analysis Generalised Estimating Equations (GEE) were used to analyse the primary and secondary outcomes. GEE models were applied to account for the correlation of repeated measures within subjects. The dependent variables in the models were user satisfaction (PACES-8 scores) and perceived exertion (Borg scale scores), while the independent variables were condition (RL vs control) and trial week. Covariates included age, gender, and baseline physical activity levels, with participant ID included as a subject effect.

Being tested
Reinforcement Learning (RL) Personalised Exercise Prescription via i80 BPM App, Generic Non-Personalised Exercise Prescription via i80 BPM App
Keywords
Reinforcement Learning, mHealth, Exercise therapy
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Reinforcement Learning (RL) Personalised Exercise Prescription via i80 BPM AppDevice

    This intervention involved the use of a smartphone app, i80 BPM, which delivered personalised exercise prescriptions using a reinforcement learning (RL) model. The RL algorithm tailored the exercise sessions by adapting variables such as intensity, duration, and exercise type based on individual user preferences, real-time feedback, and performance data. This dynamic personalisation was designed to enhance user satisfaction and engagement over the 12-week study period. Participants completed three exercise sessions per week.

  • Generic Non-Personalised Exercise Prescription via i80 BPM AppDevice

    This intervention used the same i80 BPM smartphone app to deliver generic, pre-designed exercise sessions that did not adapt based on user preferences or feedback. The exercise sessions were standardised for all participants, with no customisation. The control arm served as a comparator to evaluate the impact of personalised, RL-driven exercise prescriptions. Participants completed three exercise sessions per week.

Study groups in NCT06653049
Study groupRoleWhat they receive
Reinforcement Learning (RL) Personalised Exercise PrescriptionExperimentalParticipants in this arm received personalised exercise sessions via the i80 BPM app, which utilised a reinforcement learning (RL) model. The RL algorithm adapted exercise parameters (e.g., intensity, type of exercise, duration) based on individual preferences, performance, and feedback to optimise user satisfaction and engagement. Sessions were tailored specifically to each participant over the 12-week trial period.
Receives: Device: Reinforcement Learning (RL) Personalised Exercise Prescription via i80 BPM App
Generic Non-Personalised Exercise PrescriptionActive comparatorParticipants in this arm received generic, non-personalised exercise sessions using the same i80 BPM app. These sessions did not adapt to user preferences or feedback and consisted of pre-designed exercises that were uniform across all participants. This arm served as a control to compare against the RL-personalised intervention.
Receives: Device: Generic Non-Personalised Exercise Prescription via i80 BPM App

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. User Satisfaction with Exercise Sessions (PACES-8 Scale)

    User satisfaction was measured using the Physical Activity Enjoyment Scale (PACES-8), an abbreviated 8-item version. Participants rated their satisfaction with each exercise session on a scale from 1 (low satisfaction) to 5 (high satisfaction). Higher scores indicate greater enjoyment and overall satisfaction with the exercise experience. The measure was administered after each session.

    Measured: At the end of each exercise session during the 12-week study.

Secondary outcomes (1)
  1. Exercise Intensity (Borg Rating of Perceived Exertion Scale)

    Exercise intensity was assessed using the Borg Rating of Perceived Exertion (RPE) scale, ranging from 1 (very easy) to 10 (maximum exertion). Participants reported their perceived intensity of each exercise session via the app immediately after the session. Additionally, heart rate data collected from the Samsung Galaxy Fit 2 smartwatch was used to validate intensity levels.

    Measured: At the end of each exercise session during the 12-week study.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2024
  2. Study start1 Sep 2022
  3. Primary completion16 Nov 2022
  4. Study completion30 Nov 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
69 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06653049
Sponsor's protocol ID
LS-21-34-Tragos-Lawlor
Other IDs
12/RC/2289_P2
Acronym
PERFORM-RL
Status last verified
Oct 2024
First submitted
15 Oct 2024
Last updated
22 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared, as the data are considered valuable intellectual property by the industry partners involved in the study. Sharing the data would conflict with existing agreements regarding the protection and use of proprietary information.

Publications

  • Doherty C, Lambe R, O'Grady B, O'Reilly-Morgan D, Smyth B, Lawlor A, Hurley N, Tragos E. An Evaluation of the Effect of App-Based Exercise Prescription Using Reinforcement Learning on Satisfaction and Exercise Intensity: Randomized Crossover Trial. JMIR Mhealth Uhealth. 2024 Nov 26;12:e49443. doi: 10.2196/49443.

    PubMed 39622712

Questions about this trial

What is this clinical trial studying?

A study testing Reinforcement Learning (RL) Personalised Exercise Prescription via i80 BPM App and Generic Non-Personalised Exercise Prescription via i80 BPM App in people with Exercise and Mobile Applications, run by University College Dublin at 1 site in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

User Satisfaction with Exercise Sessions (PACES-8 Scale) (time frame: At the end of each exercise session during the 12-week study.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06653049, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in